Back to BL BAUPOST GROUP LLC/MA
AKBA
Showing 0 of 8 quarters
Position history for BLBAUPOST GROUP LLC/MA's holdings in AKEBIA THERAPEUTICS INC
No. Baupost Group exited its AKBA (Akebia Therapeutics) position in Q3 2020. Its Q2 2020 13F listed 15,000,000 shares worth $203.7M. Baupost Group already held AKBA in its Q4 2018 13F, the earliest on record, and held it in 7 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.